The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results of the prospective randomized controlled trial VOG-01: Neoadjuvant endocrine therapy ribociclib + fulvestrant + GnRH-a versus chemotherapy 4 AC + 4 T for early HR+/HER2-negative breast cancer in premenopausal patients.
 
Rashida Orlova
No Relationships to Disclose
 
Almira Vakhitova
No Relationships to Disclose
 
Mark Gluzman
No Relationships to Disclose
 
Eldar Topuzov
No Relationships to Disclose
 
Petr Krivorotko
No Relationships to Disclose
 
Alexandra Androsova
No Relationships to Disclose
 
Ekaterina Serikova
No Relationships to Disclose
 
Vitaly Skvortsov
No Relationships to Disclose